Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Haemophilia ; 17(4): 620-4, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21323803

RESUMO

Stopping or preventing local bleeding in patients with inherited bleeding disorders linked to abnormal platelet function is traditionally treated by transfusion of blood cell products or recombinant factor VIIa. We now report the use in such patients of autologous platelet-rich clots as an aid to preventing bleeding and to facilitating tissue regeneration at superficial sites. Two patients with von Willebrand's disease (VWD) type 2B and one patient with type I Glanzmann thrombasthenia were treated after tooth extraction and dental surgery. A fourth patient with platelet-type VWD underwent a skin biopsy. Whereas all four patients had a lifelong history of bleeding complications, the application of an autologous platelet-rich clot immediately after surgery combined with tranexamic acid intake to slow fibrinolysis prevented blood loss and resulted in rapid and normal healing. This new procedure is simple, safe and inexpensive; it provides extra security for patients with a bleeding risk undergoing dentistry or superficial surgery.


Assuntos
Plasma Rico em Plaquetas , Hemorragia Pós-Operatória/prevenção & controle , Trombastenia/terapia , Doença de von Willebrand Tipo 1/terapia , Doença de von Willebrand Tipo 2/terapia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Trombastenia/cirurgia , Transplante Autólogo , Doença de von Willebrand Tipo 1/cirurgia , Doença de von Willebrand Tipo 2/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA